RAPT Therapeutics (RAPT) Equity Ratio: 2020-2024
Historic Equity Ratio for Therapeutics (RAPT) over the last 5 years, with Sep 2024 value amounting to 0.88.
- Therapeutics' Equity Ratio rose 1.77% to 0.88 in Q3 2024 from the same period last year, while for Sep 2024 it was 0.88, marking a year-over-year increase of 1.77%. This contributed to the annual value of 0.85 for FY2023, which is 7.89% down from last year.
- According to the latest figures from Q3 2024, Therapeutics' Equity Ratio is 0.88, which was up 2.53% from 0.86 recorded in Q2 2024.
- In the past 5 years, Therapeutics' Equity Ratio ranged from a high of 0.94 in Q2 2021 and a low of 0.84 during Q1 2024.
- Its 3-year average for Equity Ratio is 0.88, with a median of 0.89 in 2023.
- As far as peak fluctuations go, Therapeutics' Equity Ratio grew by 8.79% in 2021, and later declined by 7.89% in 2023.
- Over the past 5 years, Therapeutics' Equity Ratio (Quarterly) stood at 0.88 in 2020, then increased by 7.15% to 0.94 in 2021, then fell by 1.85% to 0.92 in 2022, then declined by 7.89% to 0.85 in 2023, then grew by 1.77% to 0.88 in 2024.
- Its last three reported values are 0.88 in Q3 2024, 0.86 for Q2 2024, and 0.84 during Q1 2024.